Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017
Fore Pharma announced the results of its Non-Small Cell Lung Cancer patients study in a new report ‘Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Non-Small Cell Lung Cancer epidemiology, Non-Small Cell Lung Cancer diagnosed patients, and Non-Small Cell Lung Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Non-Small Cell Lung Cancer derived from epidemiological analysis, percentage of patients diagnosed with Non-Small Cell Lung Cancer, and percentage of patients treated with a therapy.
The study helps executives estimate Non-Small Cell Lung Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Non-Small Cell Lung Cancer prevalence, Non-Small Cell Lung Cancer diagnosis rate, and Non-Small Cell Lung Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report:
- Non-Small Cell Lung Cancer Patient Flow
- Non-Small Cell Lung Cancer Prevalence
- Non-Small Cell Lung Cancer Diagnosed Patients
- Non-Small Cell Lung Cancer Treated Patients
- 1. Non-Small Cell Lung Cancer: Disease Definition
- 2. Global Non-Small Cell Lung Cancer Patient Flow
- 2A. Global Non-Small Cell Lung Cancer Prevalence
- 2B. Global Non-Small Cell Lung Cancer Diagnosed Patients
- 2C. Global Non-Small Cell Lung Cancer Treated Patients
- 3. Non-Small Cell Lung Cancer Patient Flow in the US
- 3A. Non-Small Cell Lung Cancer Prevalence in the US
- 3B. Non-Small Cell Lung Cancer Diagnosed Patients in the US
- 3C. Non-Small Cell Lung Cancer Treated Patients in the US
- 4. Non-Small Cell Lung Cancer Patient Flow in Europe
- 4A. Non-Small Cell Lung Cancer Prevalence in Europe
- 4B. Non-Small Cell Lung Cancer Diagnosed Patients in Europe
- 4C. Non-Small Cell Lung Cancer Treated Patients in Europe
- 5. Non-Small Cell Lung Cancer Patient Flow in Germany
- 5A. Non-Small Cell Lung Cancer Prevalence in Germany
- 5B. Non-Small Cell Lung Cancer Diagnosed Patients in Germany
- 5C. Non-Small Cell Lung Cancer Treated Patients in Germany
- 6. Non-Small Cell Lung Cancer Patient Flow in France
- 6A. Non-Small Cell Lung Cancer Prevalence in France
- 6B. Non-Small Cell Lung Cancer Diagnosed Patients in France
- 6C. Non-Small Cell Lung Cancer Treated Patients in France
- 7. Non-Small Cell Lung Cancer Patient Flow in Spain
- 7A. Non-Small Cell Lung Cancer Prevalence in Spain
- 7B. Non-Small Cell Lung Cancer Diagnosed Patients in Spain
- 7C. Non-Small Cell Lung Cancer Treated Patients in Spain
- 8. Non-Small Cell Lung Cancer Patient Flow in Italy
- 8A. Non-Small Cell Lung Cancer Prevalence in Italy
- 8B. Non-Small Cell Lung Cancer Diagnosed Patients in Italy
- 8C. Non-Small Cell Lung Cancer Treated Patients in Italy
- 9. Non-Small Cell Lung Cancer Patient Flow in UK
- 9A. Non-Small Cell Lung Cancer Prevalence in UK
- 9B. Non-Small Cell Lung Cancer Diagnosed Patients in UK
- 9C. Non-Small Cell Lung Cancer Treated Patients in UK
- 10. Non-Small Cell Lung Cancer Patient Flow in Japan
- 10A. Non-Small Cell Lung Cancer Prevalence in Japan
- 10B. Non-Small Cell Lung Cancer Diagnosed Patients in Japan
- 10C. Non-Small Cell Lung Cancer Treated Patients in Japan
- 11. Research Methodology
- List of Tables
- Table 1: Global Non-Small Cell Lung Cancer Patient Flow, 2016
- Table 2: Global Non-Small Cell Lung Cancer Patient Flow Forecast, 2016 - 2025
- Table 3: Non-Small Cell Lung Cancer Patient Flow in the US, 2016
- Table 4: Non-Small Cell Lung Cancer Patient Flow Forecast in the US, 2016 - 2025
- Table 5: Non-Small Cell Lung Cancer Patient Flow in Europe, 2016
- Table 6: Non-Small Cell Lung Cancer Patient Flow Forecast in Europe, 2016 - 2025
- Table 7: Non-Small Cell Lung Cancer Patient Flow in Germany, 2016
- Table 8: Non-Small Cell Lung Cancer Patient Flow Forecast in Germany, 2016 - 2025
- Table 9: Non-Small Cell Lung Cancer Patient Flow in France, 2016
- Table 10: Non-Small Cell Lung Cancer Patient Flow Forecast in France, 2016 - 2025
- Table 11: Non-Small Cell Lung Cancer Patient Flow in Spain, 2016
- Table 12: Non-Small Cell Lung Cancer Patient Flow Forecast in Spain, 2016 - 2025
- Table 13: Non-Small Cell Lung Cancer Patient Flow in Italy, 2016
- Table 14: Non-Small Cell Lung Cancer Patient Flow Forecast in Italy, 2016 - 2025
- Table 15: Non-Small Cell Lung Cancer Patient Flow in UK, 2016
- Table 16: Non-Small Cell Lung Cancer Patient Flow Forecast in UK, 2016 - 2025
- Table 17: Non-Small Cell Lung Cancer Patient Flow in Japan, 2016
- Table 18: Non-Small Cell Lung Cancer Patient Flow Forecast in Japan, 2016 - 2025
- List of Figures
- Figure 1: Global Non-Small Cell Lung Cancer Patient Flow, 2016
- Figure 2: Global Non-Small Cell Lung Cancer Patient Flow Forecast, 2016 - 2025
- Figure 3: Non-Small Cell Lung Cancer Patient Flow in the US, 2016
- Figure 4: Non-Small Cell Lung Cancer Patient Flow Forecast in the US, 2016 - 2025
- Figure 5: Non-Small Cell Lung Cancer Patient Flow in Europe, 2016
- Figure 6: Non-Small Cell Lung Cancer Patient Flow Forecast in Europe, 2016 - 2025
- Figure 7: Non-Small Cell Lung Cancer Patient Flow in Germany, 2016
- Figure 8: Non-Small Cell Lung Cancer Patient Flow Forecast in Germany, 2016 - 2025
- Figure 9: Non-Small Cell Lung Cancer Patient Flow in France, 2016
- Figure 10: Non-Small Cell Lung Cancer Patient Flow Forecast in France, 2016 - 2025
- Figure 11: Non-Small Cell Lung Cancer Patient Flow in Spain, 2016
- Figure 12: Non-Small Cell Lung Cancer Patient Flow Forecast in Spain, 2016 - 2025
- Figure 13: Non-Small Cell Lung Cancer Patient Flow in Italy, 2016
- Figure 14: Non-Small Cell Lung Cancer Patient Flow Forecast in Italy, 2016 - 2025
- Figure 15: Non-Small Cell Lung Cancer Patient Flow in UK, 2016
- Figure 16: Non-Small Cell Lung Cancer Patient Flow Forecast in UK, 2016 - 2025
- Figure 17: Non-Small Cell Lung Cancer Patient Flow in Japan, 2016
- Figure 18: Non-Small Cell Lung Cancer Patient Flow Forecast in Japan, 2016 - 2025
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook